Synovial Sarcoma Is a Stem Cell Malignancy
Norifumi Naka(University of the Witwatersrand), Kazuyuki Itoh(Fukuoka Tokushukai Hospital)
Cited by 202
Related Papers
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles
|International Journal of Oncology|2004|100
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
|Cancer Science|2009|94
Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in Japan
|Oncology Reports|2008|60
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study
|World Journal of Surgical Oncology|2018|55